Patient Guide: Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 206 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03711032
Status: ACTIVE_NOT_RECRUITING
Condition: High-risk Non-muscle Invasive Bladder Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 206 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Anchorage, Alaska
  • Phoenix, Arizona
  • Tucson, Arizona
  • • And 203 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily